A., Corash, L
Moderate doses (40-80 mcg) may produce mild glucose-lowering effects, very in fasted states
Janelidze S, Hertze J, Ngga K, Nilsson K, Swedish BioFINDER Study Group, Nilsson C, Wennstrm M, van Westen D, Blennow K, Zetterberg H, Hansson O (2017) Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype
information on allocation concealment, randomization efficiency, and withdrawal was not consistently disclosed
But their regulatory trajectories differ
Future Sci OA Mar:FSO797 Al-kuraishy HM, Al-Gareeb AI, Elekhnawy E, Batiha GE (2022) Dipyridamole and adenosinergic pathway in Covid-19: a juice or holy grail